WhyLabs logo

WhyLabs

WhyLabs is a Seattle-based observability startup in the technology and software sector, known for participating in Find Ventures...

Facts

HQ
Seattle, Washington, USA
Sectors
AI, Machine Learning, Observability, Security, SaaS
Founded
2019
Type
Corporation Seattle business license
Registered name
WhyLabs Inc Seattle business license
Stage
startup

Apple Quietly Acquires Seattle AI Startup WhyLabs in 2025, Expanding Local AI Expertise

Apple appears to have quietly acquired Seattle startup WhyLabs, which specializes in AI application monitoring, marking another in a series of AI and machine learning acquisitions in the Seattle area. The acquisition, indicated by venture capital and LinkedIn clues but not publicly confirmed, aligns with Apple's ongoing investment in AI despite reports of lagging behind competitors.

Former Microsoft engineers Koukoumidis and Elachqar launch Bellevue AI lab Oumi with $10M seed round

Bellevue-based AI lab Oumi, founded by former Microsoft engineers Manos Koukoumidis and Oussama Elachqar, launched with $10 million in seed funding to build a collaboration platform for AI researchers and developers and has partnered with academics from Caltech, MIT, UW and Stanford. The startup has 10 employees, one research fellow, dozens of founding scholars, and space in UW's Global Innovation Exchange in Bellevue.

WhyLabs, an AI2 spinout led by CEO Alessya Visnjic, raises $10M and launches AI Observatory to monitor live ML models

WhyLabs, a Seattle startup spun out of AI2 and led by CEO Alessya Visnjic, raised $10 million and launched AI Observatory, a tool to monitor and diagnose live machine-learning models for anomalies and "model meltdowns." The platform offers an open-source library and real-time alerts, positioning WhyLabs as a Datadog-like monitoring service focused on backend ML/AI, and saw adoption by over a dozen organizations in its first week.

Modulus Therapeutics, spun out of the Allen Institute for AI, raises $3.5M to engineer enhanced NK cell therapies

Modulus Therapeutics, a Seattle cell-therapy startup spun out of the Allen Institute for AI, raised $3.5 million in seed funding to use lab research and machine learning to engineer enhanced natural killer (NK) cells for anti-tumor therapies. Founders Max Darnell and Bryce Daines aim to develop a discovery platform to generate NK cell product candidates for larger cellular therapy companies.

Madison McIlwain, daughter of Madrona’s Matt McIlwain, becomes associate at Defy and pursues fashion, e-commerce investing

Madison McIlwain, daughter of Madrona Venture Group managing director Matt McIlwain, followed her father's path into venture capital and is now an associate at early-stage VC Defy, bringing interests in fashion, e-commerce and the consumer supply chain. The article profiles how growing up with dinner-table discussions about startups shaped her approach to investing and highlights Defy’s co-investments with Madrona in Seattle companies like Nautilus Biotechnology and WhyLabs.

WhyLabs, AI2 Spinout Led by Ex-Amazon Engineers, Raises $4M from Madrona, Bezos Expeditions and Others

WhyLabs, an AI monitoring startup spun out of the Allen Institute for AI, emerged from stealth after raising $4 million from investors including Madrona, Defy Partners, Bezos Expeditions and Ascend VC to commercialize a platform for monitoring ML data and models. The company is led by CEO Alessya Visnjic, joined by former Amazon ML engineers Andy Dang and Sam Gracie plus ex-Madrona principal Maria Karaivanova.

Online